BIOMEDIQ A/S: Financial statements 2017
CVR: 31176891
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIOMEDIQ A/S (CVR 31176891) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 1,759,691 and a net result of DKK -348,790 compared with DKK -915,374 the year before. That is a decrease of 41% compared with the year before. The profit margin was -19.8%. Equity in the 2017 report amounted to DKK 18,496. The solvency ratio was 0.6%. The company had 3 employees in the financial year.
- Revenue
- DKK 1,759,691
- Gross Profit
- DKK 946,650
- Profit/Loss
- DKK -348,790
- Equity
- DKK 18,496
- Total Assets
- DKK 2,971,613
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 1.8M | 947K | -349K | 18K | 3 |
| 2016 | 3M | 1.6M | -915K | 367K | 5 |
| 2015 | 6.8M | 4.6M | -203K | 1.3M | - |
| 2014 | 7.5M | 5M | 51K | 1.5M | - |
| 2013 | 5.9M | 3.6M | 24K | 435K | - |
Official annual report
Keep an eye on BIOMEDIQ A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
BIOMEDIQ A/S has published its annual report for 2016. Revenue came to DKK 2,981,218, and the net result was DKK -915,374.
About BIOMEDIQ A/S
BIOMEDIQ A/S is a Danish company of the type Aktieselskab based in København K, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC IMAGING TECHNOLOGY A/S and NORDIC BIOSCIENCE IMAGING A/S. The management consists of Mads Nielsen. The board consists of Pieter Kroese (chair), Mads Nielsen and Martin Lillholm. The company is owned by Screenpoint Medical B.V. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -304,901 and a net result of DKK -977,037 compared with DKK -56,669 the year before. Equity in the 2025 report amounted to DKK -979,433.
